Axim Biotechnologies, Inc.
AXIM· OTC
AXIMAxim Biotechnologies, Inc.
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001514955-13-000017
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $10.83K | $10.83K | $0.00 |
| Net Income | -$5.82K | -$510.00 | $0.00 |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end
